Inspire Investing’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,370
Closed -$383K 827
2023
Q4
$383K Buy
10,370
+2,366
+30% +$89.1K 0.04% 619
2023
Q3
$306K Sell
8,004
-655
-8% -$26.8K 0.04% 691
2023
Q2
$312K Buy
8,659
+1,546
+22% +$52.7K 0.04% 738
2023
Q1
$272K Buy
7,113
+2,982
+72% +$140K 0.03% 715
2022
Q4
$235K Sell
4,131
-1,070
-21% -$54.8K 0.03% 628
2022
Q3
$206K Buy
5,201
+460
+10% +$20.3K 0.03% 623
2022
Q2
$209K Sell
4,741
-1,176
-20% -$50.9K 0.03% 755
2022
Q1
$236K Sell
5,917
-189
-3% -$6.73K 0.03% 497
2021
Q4
$246K Buy
6,106
+298
+5% +$11.1K 0.03% 701
2021
Q3
$236K Buy
+5,808
New +$243K 0.03% 462
2021
Q1
Sell
-16,538
Closed -$706K 662
2020
Q4
$706K Buy
+16,538
New +$594K 0.16% 121
2020
Q3
Sell
-9,796
Closed -$263K 486
2020
Q2
$263K Sell
9,796
-3,761
-28% -$84.8K 0.09% 259
2020
Q1
$244K Buy
+13,557
New +$257K 0.1% 289
2019
Q4
Sell
-11,502
Closed -$178K 362
2019
Q3
$178K Buy
11,502
+1,337
+13% +$22K 0.07% 348
2019
Q2
$175K Buy
+10,165
New +$164K 0.07% 282
2018
Q1
Sell
-2,890
Closed -$59K 402
2017
Q4
$59K Buy
+2,890
New +$53.1K 0.05% 346

Other funds holding HALO

Inspire Investing's HALO Position: Q1 2024 in Review

Inspire Investing sold out of Halozyme (HALO) in Q1 2024, closing a stake of 10,370 shares — an estimated $383K sold.

Inspire Investing first reported a position in HALO in Q4 2017 and held it in 16 quarters. The position peaked at $706K in Q4 2020. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

  • Inspire Investing reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
  • Inspire Investing sold 10,370 Halozyme shares in Q1 2024, an estimated $383K.
  • Inspire Investing first reported a position in Halozyme in Q4 2017 and held it in 16 quarters.
  • Inspire Investing's Halozyme position peaked at $706K in Q4 2020.
  • 414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Inspire Investing's 13F filing for Q1 2024, filed 7 May 2024.